Quantcast

Latest Brain tumor Stories

2014-06-22 23:03:27

Dr. Leroy Hood, Institute for Systems Biology President, Accepts CEF’s Annual Inspirational Award on Dr. Foltz’ Behalf Seattle, WA (PRWEB) June 22, 2014 Dr. Greg Foltz, longtime supporter of the Chris Elliott Fund, and eminent Seattle neurosurgeon and researcher, was this year’s recipient of CEF’s Inspirational Award, presented annually at the Brains Matter Awareness and Celebration Luncheon. As a young man, Dr. Foltz gave up a promising career as a pianist to pursue a career as a...

2014-06-20 08:23:49

Company Refutes Latest Feuerstein False Headline and Attacks BETHESDA, Md., June 20, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today refuted Adam Feuerstein's latest false headline and attack on the Company, and reaffirmed the Company's recent interim data announcements from its Phase I/II clinical trial of DCVax-Direct for all inoperable solid tumors....

2014-06-18 23:02:56

New research report “Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany” elaborated by GBI Research is now available at MarketPublishers.com. According to the study, in 2019, the world GBM market value is anticipated to amount to USD 583 million. London, UK (PRWEB) June 18, 2014 Owing to the poor prognosis under presently available treatment options, therapies with high...

2014-06-17 23:09:55

American Brain Tumor Association’s Team Breakthrough Racing; Raising Funds to Advance the Understanding and Treatment of Brain Tumors (PRWEB) June 17, 2014 Each day, 500 people are diagnosed with a brain tumor. One day two years ago, Holly Remmers’ mother was one of those 500. Her mother was diagnosed with a glioblastoma and lost her battle within a year of diagnosis. After her mother’s brain tumor diagnosis, Remmers didn't know where to turn or what to do, so she started...

2014-06-17 23:06:43

New thermal therapy provides options for patients with tumors that otherwise would be deemed inoperable. Less invasive than traditional surgery, this new procedure shortens patients' recovery and hospital stays. Kansas City, Missouri (PRWEB) June 17, 2014 Neurosurgeons at the Saint Luke’s Marion Bloch Neuroscience Institute (SLMBNI) are using MRI-guided laser technology to successfully ablate malignant brain tumors, becoming the first in the region to use this FDA-cleared system....

2014-06-17 23:06:04

Neurosurgeon Peter Nakaji has published four academic papers with colleagues, each discussing technology and the intraoperative diagnosis of brain tumors. Phoenix, AZ (PRWEB) June 17, 2014 Acclaimed neurosurgeon Peter Nakaji has joined with several of his colleagues to publish four academic papers discussing methods of diagnosing tumors in the human brain. These methods would allow for the diagnosis of tumors either in the operating room during brain surgery or shortly thereafter....

2014-06-17 12:28:46

Children's Hospitals and Clinics of Minnesota performs first known minimally invasive Visualase surgery on rare mature teratoma tumor; results showcased on nationally syndicated talk show, The Doctors ST. PAUL, Minn., June 17, 2014 /PRNewswire/ -- A rare brain tumor in a previously inoperable area of an 8-year-old boy's brain remains dormant nearly four months after a second laser ablation surgery, Children's Hospitals and Clinics of Minnesota reported today upon the story being...

2014-06-17 11:02:54

Ohio State University Giving low doses of a particular targeted agent with a cancer-killing virus might improve the effectiveness of the virus as a treatment for cancer, according to a study led by researchers with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). Viruses that are designed to kill cancer cells – oncolytic viruses – have shown promise in clinical trials for the...

2014-06-17 08:29:17

SAN DIEGO, June 17, 2014 /PRNewswire/ -- DNAtrix, Inc., experts in oncolytic virus development, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track status for its lead product, DNX-2401, a replication competent adenovirus, for patients with recurrent gliobastoma. The FDA gives Fast Track status to facilitate the development of new products for serious or life-threatening conditions which demonstrate the potential to address unmet medical needs,...

2014-06-15 14:59:20

Broad Institute of MIT and Harvard Cellular makeup of glioblastoma more diverse than previously thought Scientists from the Broad Institute and Massachusetts General Hospital (MGH) have conducted a first-of-its-kind study that characterizes the cellular diversity within glioblastoma tumors from patients. The study, which looked at the expression of thousands of genes in individual cells from patient tumors, revealed that the cellular makeup of each tumor is more heterogeneous than...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.